Scientists have found that overexpression of metallothionein-1 (MT-1A and MT-1B) modulates the pathogenesis of AD through antioxidant, anti-inflammatory, and heavy metal binding [52]. The gene discussed is MT1B; the disease is Alzheimer disease.